1,2-dehydrosalsolinol has been researched along with salsolinol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allievi, C; Bellotti, V; Benedetti, MS; Dordain, G; Dostert, P | 1 |
Dostert, P; Maruyama, W; Minami, M; Nagatsu, T; Naoi, M; Takahashi, A; Takahashi, T | 1 |
Antonin, KH; Bieck, PR; Dostert, P; Farger, G; Nilsson, EB; Schmidt, EK; Strolin Benedetti, M; Waldmeier, PC | 1 |
Allievi, C; Della Vedova, F; Dordain, G; Dostert, P; Durif, F; La Croix, R; Strolin Benedetti, M; Vernay, D | 1 |
4 other study(ies) available for 1,2-dehydrosalsolinol and salsolinol
Article | Year |
---|---|
Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects.
Topics: Adult; Benserazide; Dopamine; Drug Combinations; Female; Humans; Hydrazines; Isoquinolines; Levodopa; Male; Stereoisomerism | 1990 |
Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines.
Topics: Animals; Cell Division; Cell Survival; Dopamine; Isoquinolines; PC12 Cells; Quinolinium Compounds; Rats; Salsoline Alkaloids; Structure-Activity Relationship; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 1993 |
Clinical pharmacology of the new COMT inhibitor CGP 28,014.
Topics: Amidines; Animals; Benserazide; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Isoquinolines; Kinetics; Methoxyhydroxyphenylglycol; Norepinephrine; Pyridones; Rats; Tyrosine; Vanilmandelic Acid | 1993 |
Dopamine-derived tetrahydroisoquinolines and Parkinson's disease.
Topics: Aged; Aged, 80 and over; Female; Humans; Isoquinolines; Male; Middle Aged; Parkinson Disease; Reference Values; Salsoline Alkaloids | 1993 |